Shanghai Junshi Biosciences' (HKG:1877, SHA:688180) chairman, Xiong Jun, raised his shareholding for 12.2 million yuan, according to a Hong Kong filing on Monday.
The pharmaceutical company's Shanghai shares rose over 2% in Tuesday's morning trade.
Xiong acquired an additional 365,382 shares, or 0.04% of the company's total share capital.
The move is part of Xiong's plan to increase his stake by 50 million yuan to 100 million yuan. The share increase transaction is still ongoing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.